Noninvasive Tests for Prognosticating Outcomes in Patients With Chronic Liver Disease in Pregnancy: Ready for Prime Time?

Tatyana Kushner, Monika Sarkar, Tram Tran

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Rates of cirrhosis and pregnancy in women of reproductive age are increasing, making pregnancy-specific prognostic markers of disease severity increasingly important. Gonsalkorala et al. describe albumin-bilirubin score and aspartate aminotransferase-to-platelet ratio index as superior prognostic tools to the Model for End-Stage Liver Disease (MELD) score in predicting live births and gestation beyond 37 weeks in pregnant women with cirrhosis, among 165 pregnancies in women with chronic liver disease. However, further efforts are needed to identify diagnostic and prognostic tools during pregnancy, as well as to refine and implement a multidisciplinary team-centered approach to the care of women with chronic liver disease during pregnancy.

Original languageEnglish
Pages (from-to)209-211
Number of pages3
JournalAmerican Journal of Gastroenterology
Volume114
Issue number2
DOIs
StatePublished - 1 Feb 2019

Fingerprint

Dive into the research topics of 'Noninvasive Tests for Prognosticating Outcomes in Patients With Chronic Liver Disease in Pregnancy: Ready for Prime Time?'. Together they form a unique fingerprint.

Cite this